Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124412952 | 12441295 | 2 | F | 20160405 | 20160721 | 20160607 | 20160802 | EXP | US-ROCHE-1738075 | ROCHE | 71.40 | YR | F | Y | 79.90000 | KG | 20160802 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124412952 | 12441295 | 1 | PS | Polatuzumab Vedotin | POLATUZUMAB VEDOTIN | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE ADMINISTERED PRIOR TO VOMITING AND SEPTIC SHOCK WAS 150.5 MG ON 29/MAR/2016. | N | 1149854 | 109409 | ||||||||
| 124412952 | 12441295 | 2 | SS | Obinutuzumab | OBINUTUZUMAB | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE ADMINISTERED PRIOR TO VOMITING AND SEPTIC SHOCK WAS 1000 MG ON 29/MAR/2016. | N | 1147552 | 125486 | SOLUTION FOR INFUSION | |||||||
| 124412952 | 12441295 | 3 | SS | Doxorubicin | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE ADMINISTERED PRIOR TO VOMITING AND SEPTIC SHOCK WAS 96.5 MG ON 29/MAR/2016. | N | 0 | |||||||||
| 124412952 | 12441295 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE ADMINISTERED PRIOR TO VOMITING AND SEPTIC SHOCK WAS 1447.5 MG ON 29/MAR/2016. | N | 0 | |||||||||
| 124412952 | 12441295 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | MOST RECENT DOSE ADMINISTERED PRIOR TO VOMITING AND SEPTIC SHOCK WAS 100 MG ON 02/APR/2016. | N | 0 | |||||||||
| 124412952 | 12441295 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | |||||||||
| 124412952 | 12441295 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | |||||||||
| 124412952 | 12441295 | 8 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 20 | MG | |||||||||
| 124412952 | 12441295 | 9 | C | COREG | CARVEDILOL | 1 | Oral | 0 | 12.5 | MG | |||||||||
| 124412952 | 12441295 | 10 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Oral | 0 | 60 | MG | |||||||||
| 124412952 | 12441295 | 11 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 124412952 | 12441295 | 12 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | |||||||||
| 124412952 | 12441295 | 13 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | |||||||||
| 124412952 | 12441295 | 14 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | |||||||||
| 124412952 | 12441295 | 15 | C | METAMUCIL | PLANTAGO SEED | 1 | Oral | 0 | 1000 | MG | |||||||||
| 124412952 | 12441295 | 16 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 20 | MG | |||||||||
| 124412952 | 12441295 | 17 | C | ACETAMINOPHEN/OXYCODONE | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 7.5 | MG | |||||||||
| 124412952 | 12441295 | 18 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | ANTI-VIRAL PROPHYLAXIS | 0 | 200 | MG | ||||||||
| 124412952 | 12441295 | 19 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | URIC ACID PROPHYLAXIS | 0 | 300 | MG | ||||||||
| 124412952 | 12441295 | 20 | C | DIFLUCAN | FLUCONAZOLE | 1 | Oral | 0 | 100 | MG | |||||||||
| 124412952 | 12441295 | 21 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 20 | UG | |||||||||
| 124412952 | 12441295 | 22 | C | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | Intravenous (not otherwise specified) | 0 | 2 | G | |||||||||
| 124412952 | 12441295 | 23 | C | CALCIUM GLUCONATE. | CALCIUM GLUCONATE | 1 | Intravenous (not otherwise specified) | 0 | 1000 | MG | |||||||||
| 124412952 | 12441295 | 24 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | 0 | 650 | MG | |||||||||
| 124412952 | 12441295 | 25 | C | PHENYLEPHRINE | PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 20 | MG | |||||||||
| 124412952 | 12441295 | 26 | C | DEXMEDETOMIDINE. | DEXMEDETOMIDINE | 1 | Intravenous (not otherwise specified) | 0 | 200 | UG | |||||||||
| 124412952 | 12441295 | 27 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 0 | 1250 | MG | |||||||||
| 124412952 | 12441295 | 28 | C | VANCOMYCIN | VANCOMYCIN | 1 | 0 | ||||||||||||
| 124412952 | 12441295 | 29 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 1 | G | |||||||||
| 124412952 | 12441295 | 30 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124412952 | 12441295 | 1 | B-cell lymphoma |
| 124412952 | 12441295 | 2 | B-cell lymphoma |
| 124412952 | 12441295 | 3 | B-cell lymphoma |
| 124412952 | 12441295 | 4 | B-cell lymphoma |
| 124412952 | 12441295 | 5 | B-cell lymphoma |
| 124412952 | 12441295 | 6 | Coronary artery disease |
| 124412952 | 12441295 | 7 | Coronary artery disease |
| 124412952 | 12441295 | 8 | Anxiety |
| 124412952 | 12441295 | 9 | Hypertension |
| 124412952 | 12441295 | 10 | Gastrooesophageal reflux disease |
| 124412952 | 12441295 | 11 | Hypertension |
| 124412952 | 12441295 | 12 | Hyperlipidaemia |
| 124412952 | 12441295 | 13 | Coronary artery disease |
| 124412952 | 12441295 | 14 | Hypersensitivity |
| 124412952 | 12441295 | 15 | Constipation |
| 124412952 | 12441295 | 16 | Hypertension |
| 124412952 | 12441295 | 17 | Pain |
| 124412952 | 12441295 | 18 | Prophylaxis |
| 124412952 | 12441295 | 19 | Prophylaxis |
| 124412952 | 12441295 | 20 | Infection prophylaxis |
| 124412952 | 12441295 | 21 | Hypokalaemia |
| 124412952 | 12441295 | 22 | Hypomagnesaemia |
| 124412952 | 12441295 | 23 | Hypocalcaemia |
| 124412952 | 12441295 | 24 | Febrile neutropenia |
| 124412952 | 12441295 | 25 | Acute respiratory failure |
| 124412952 | 12441295 | 26 | Acute respiratory failure |
| 124412952 | 12441295 | 27 | Febrile neutropenia |
| 124412952 | 12441295 | 28 | Pancytopenia |
| 124412952 | 12441295 | 29 | Febrile neutropenia |
| 124412952 | 12441295 | 30 | Pancytopenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124412952 | 12441295 | HO |
| 124412952 | 12441295 | DE |
| 124412952 | 12441295 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124412952 | 12441295 | Septic shock | |
| 124412952 | 12441295 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124412952 | 12441295 | 1 | 20160128 | 0 | ||
| 124412952 | 12441295 | 2 | 20160127 | 0 | ||
| 124412952 | 12441295 | 3 | 20160127 | 0 | ||
| 124412952 | 12441295 | 4 | 20160127 | 0 | ||
| 124412952 | 12441295 | 5 | 20160127 | 0 | ||
| 124412952 | 12441295 | 18 | 20160121 | 0 | ||
| 124412952 | 12441295 | 19 | 20160121 | 0 | ||
| 124412952 | 12441295 | 20 | 20160121 | 0 | ||
| 124412952 | 12441295 | 21 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 22 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 23 | 20160406 | 20160406 | 0 | |
| 124412952 | 12441295 | 24 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 25 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 26 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 27 | 20160405 | 20160406 | 0 | |
| 124412952 | 12441295 | 29 | 20160405 | 20160406 | 0 |